BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9096591)

  • 1. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
    Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers.
    Yang D; Alt E; Rogler CE
    Cancer Res; 1993 May; 53(9):2020-7. PubMed ID: 8481904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
    Liu P; Zhao Z; Dominique B
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific expression and high oncogenic efficiency of a c-myc transgene activated by woodchuck hepatitis virus insertion.
    Etiemble J; Degott C; Renard CA; Fourel G; Shamoon B; Vitvitski-Trépo L; Hsu TY; Tiollais P; Babinet C; Buendia MA
    Oncogene; 1994 Mar; 9(3):727-37. PubMed ID: 8108115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.
    Terradillos O; Billet O; Renard CA; Levy R; Molina T; Briand P; Buendia MA
    Oncogene; 1997 Jan; 14(4):395-404. PubMed ID: 9053836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of budesonide on the methylation and mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors.
    Tao L; Li Y; Wang W; Kramer PM; Gunning WT; Lubet RA; Steele VE; Pereira MA
    Mol Carcinog; 2002 Oct; 35(2):93-102. PubMed ID: 12325039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth.
    Schirmacher P; Held WA; Yang D; Chisari FV; Rustum Y; Rogler CE
    Cancer Res; 1992 May; 52(9):2549-56. PubMed ID: 1568224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
    Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
    Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
    Kao CY; Factor VM; Thorgeirsson SS
    Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; CalabrĂ² A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of interferon alpha in primary prevention of preneoplastic lesions in a transgenic murine model of hepatocellular carcinoma related to the interaction between woodchuck hepatitis viruses and c-myc oncogene].
    Merle P; Levy R; Vitvitski L; Chevallier M; Buendia MA; Trepo C
    Gastroenterol Clin Biol; 1997; 21(6-7):459-65. PubMed ID: 9295972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
    Christensen JG; Goldsworthy TL; Cattley RC
    Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration.
    Coni P; Simbula G; de Prati AC; Menegazzi M; Suzuki H; Sarma DS; Ledda-Columbano GM; Columbano A
    Hepatology; 1993 Jun; 17(6):1109-16. PubMed ID: 8514261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.